Outcome of the meeting of the Board of Directors held on October 23, 2026: Approval of Unaudited Financial Results of the Company for the half year ended September 30, 2026; Declaration of an Interim Dividend of ?0.50/- per equity share of face value ?10/- each, i.e., @ 5% of the paid-up value per share, for the financial year 2026-27.

Date: October 23, 2026 The Bombay Stock Exchange (BSE Limited) Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400001 Scrip Name: AMWILL Company Scrip Code.: 544353 Re: Disclosure under Regulation 30, 33, and 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") read with SEBI Master Circular no. (Ref: HO/49/14/14(7)2025- CFD-POD2/I/3762/2026) January 30, 2026 (“SEBI Master Circular”). Subject: Outcome of the meeting of the Board of Directors held on October 23, 2026. Time of commencement: 12:08 P.M. (IST) / Time of conclusion: 12:35 P.M. (IST). Dear Sir/Madam, Pursuant to Regulations 30, 33, and 42 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we hereby inform you that the Board of Directors of the Company, at its meeting held today, October 23, 2026, has considered and approved the following: 1. Financial Results: The Unaudited Financial Results of the Company for the half year ended September 30, 2026, for the financial year 2026-27, along with the Statement of Profit and Loss, Statement of Assets and Liabilities and Statement of Cash Flows, in accordance with Regulation 33 of the SEBI Listing Regulations, together with the Limited Review Report thereon issued by M/s SKLR & Co. LLP., (FRN: W100362), Statutory Auditors of the Company. The results have also been reviewed by the Audit Committee. The said Unaudited Financial Results will also be available on the Company’s website at https://www.amwillhealthcare.com/. 2. Interim Dividend: Declaration of an Interim Dividend of ₹0.50/- per equity share of face value ₹10/- each, i.e., @ 5% of the paid-up value per share, for the financial year 2026-27. The Interim Dividend will be paid within 30 days from the date of declaration. 3. Record Date: Pursuant to Regulation 42 of the SEBI Listing Regulations, the Board has fixed Friday, October 30, 2026 as the “Record Date” for ascertaining the names of the members entitled to receive the Interim Dividend. This disclosure is being made in compliance with Regulation 30 of the SEBI Listing Regulations and is submitted for your information and record, will be available on the website of the Company www.amwillhealthcare.com. Thanking You. FOR AMWILL HEALTH CARE LIMITED Anshu Anshuman Company Secretary and Compliance Officer ACS65515 Encl.: i. Limited Review Report ii. Unaudited Financial Results